Clinical Trials Browser

NETWORK × Breast Neoplasms × Fluorodeoxyglucose F18 × Clear all

NCT04316117 2026-01-26

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Phase 2 Active not recruiting

Breast Neoplasms